Modified bladder cancer treatment shows promise in animal studies
ACTIV-2d, a global phase 3 trial of novel investigational COVID-19 oral antiviral agent, launches
22 August 2022What older adults do while they sit affects dementia risk, study indicates
22 August 2022Modified bladder cancer treatment shows promise in animal studies
A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show promising results and pave the way for human clinical trials. The research, conducted in close collaboration with UT Health San Antonio, was published online in June in the journal Cancer Immunology, Immunotherapy.
